Pharmacogenetic Markers for Metabolic Impairments in Treatment with Valproic Acid
Crossref DOI link: https://doi.org/10.1007/s11055-019-00861-6
Published Online: 2019-12-04
Published Print: 2020-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Drokov, A. P.
Lipatova, L. V.
Shnayder, N. A.
Nasyrova, R. F.
Text and Data Mining valid from 2019-12-04
Version of Record valid from 2019-12-04
Article History
First Online: 4 December 2019